Correlation Between Thyroid-Related Hormones and Diabetic Retinopathy in Type 2 Diabetes Mellitus Patients with Normal Thyroid Function: A Retrospective Study

References

• Rehman K, Akash M. Mechanism of generation of oxidative stress and pathophysiology of type 2 diabetes mellitus: how are they interlinked? J Cell Biochem. 2017;118(11):3577–3585. doi:10.1002/jcb.26097
   PubMed Web of Science ®Google Scholar
• White NH, Pan Q, Knowler WC, et al. Risk factors for the development of retinopathy in prediabetes and type 2 diabetes: the diabetes prevention program experience. Diabetes Care. 2022;45(11):2653–2661. doi:10.2337/dc22-0860
   PubMed Web of Science ®Google Scholar
• Yau JW, Rogers SL, Kawasaki R, et al. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care. 2012;35(3):556–564. doi:10.2337/dc11-1909
   PubMed Web of Science ®Google Scholar
• Lin KY, Hsih WH, Lin YB, et al. Update in the epidemiology, risk factors, screening, and treatment of diabetic retinopathy. J Diabetes Investig. 2021;12(8):1322–1325. doi:10.1111/jdi.13480
   PubMed Web of Science ®Google Scholar
• Song SJ, Wong TY. Current concepts in diabetic retinopathy. Diabetes Metab J. 2014;38(6):416–425. doi:10.4093/dmj.2014.38.6.416
   PubMedGoogle Scholar
• Kuo JZ, Wong TY, Rotter JI. Challenges in elucidating the genetics of diabetic retinopathy. JAMA Ophthalmol. 2014;132(1):96–107. doi:10.1001/jamaophthalmol.2013.5024
   PubMed Web of Science ®Google Scholar
• Zhang L, Krzentowski G, Albert A, et al. Risk of developing retinopathy in Diabetes Control and Complications Trial type 1 diabetic patients with good or poor metabolic control. Diabetes Care. 2001;24(7):1275–1279. doi:10.2337/diacare.24.7.1275
   PubMed Web of Science ®Google Scholar
• Enzsoly A, Hajdu RI, Turoczi Z, et al. The predictive role of thyroid hormone levels for early diabetic retinal changes in experimental rat and human diabetes. Invest Ophthalmol Vis Sci. 2021;62(6):20. doi:10.1167/iovs.62.6.20
   PubMed Web of Science ®Google Scholar
• Pessoa CN, Santiago LA, Santiago DA, et al. Thyroid hormone action is required for normal cone opsin expression during mouse retinal development. Invest Ophthalmol Vis Sci. 2008;49(5):2039–2045. doi:10.1167/iovs.07-0908
   PubMed Web of Science ®Google Scholar
• Zou J, Li Z, Tian F, et al. Association between normal thyroid hormones and diabetic retinopathy in patients with type 2 diabetes. Biomed Res Int. 2020;2020:8161797. doi:10.1155/2020/8161797
   PubMed Web of Science ®Google Scholar
• Falkowski B, Rogowicz-Frontczak A, Grzelka A, et al. Higher free triiodothyronine concentration is associated with lower prevalence of microangiopathic complications and better metabolic control in adult euthyroid people with type 1 diabetes. Endocrine. 2018;60(3):458–465. doi:10.1007/s12020-018-1582-8
   PubMed Web of Science ®Google Scholar
• Cao X, Lu M, Xie RR, et al. A high TSH level is associated with diabetic macular edema: a cross-sectional study of patients with type 2 diabetes mellitus. Endocr Connect. 2022;11(7). doi:10.1530/EC-22-0122
   Web of Science ®Google Scholar
• Heidari Z, Asadzadeh R. Subclinical hypothyroidism is a risk factor for diabetic retinopathy in patients with type 2 diabetes mellitus. Med J Islam Repub Iran. 2021;35:186. doi:10.47176/mjiri.35.186
   PubMedGoogle Scholar
• Bao W, Dar S, Zhu Y, et al. Plasma concentrations of lipids during pregnancy and the risk of gestational diabetes mellitus: a longitudinal study. J Diabetes. 2018;10(6):487–495. doi:10.1111/1753-0407.12563
   PubMed Web of Science ®Google Scholar
• American Diabetes Association Professional Practice Committee, American Diabetes Association Professional Practice Committee. 2. Classification and diagnosis of diabetes: standards of medical care in diabetes-2022. Diabetes Care. 2022;45(Suppl 1):S17–S38. doi:10.2337/dc22-S002
   PubMedGoogle Scholar
• Rao H, Jalali JA, Johnston TP, et al. Emerging roles of dyslipidemia and hyperglycemia in diabetic retinopathy: molecular mechanisms and clinical perspectives. Front Endocrinol. 2021;12:620045. doi:10.3389/fendo.2021.620045
   PubMed Web of Science ®Google Scholar
• Lin D, Qin R, Guo L. Thyroid stimulating hormone aggravates diabetic retinopathy through the mitochondrial apoptotic pathway. J Cell Physiol. 2022;237(1):868–880. doi:10.1002/jcp.30563
   PubMed Web of Science ®Google Scholar
• Iwen KA, Schroder E, Brabant G. Thyroid hormones and the metabolic syndrome. Eur Thyroid J. 2013;2(2):83–92. doi:10.1159/000351249
   PubMedGoogle Scholar
• Maiden MJ, Torpy DJ. Thyroid Hormones in Critical Illness. Crit Care Clin. 2019;35(2):375–388. doi:10.1016/j.ccc.2018.11.012
   PubMed Web of Science ®Google Scholar
• Cheng SY, Leonard JL, Davis PJ. Molecular aspects of thyroid hormone actions. Endocr Rev. 2010;31(2):139–170. doi:10.1210/er.2009-0007
   PubMed Web of Science ®Google Scholar
• Glaschke A, Weiland J, Del TD, et al. Thyroid hormone controls cone opsin expression in the retina of adult rodents. J Neurosci. 2011;31(13):4844–4851. doi:10.1523/JNEUROSCI.6181-10.2011
   PubMed Web of Science ®Google Scholar
• Bapputty R, Sapa H, Masaru M, et al. Diabetes modulates iodothyronine deiodinase 2 expression in the mouse retina: a role for thyroid hormone in the pathogenesis of diabetic retinopathy. Invest Ophthalmol Vis Sci. 2023;64(15):3. doi:10.1167/iovs.64.15.3
   PubMedGoogle Scholar
• Forini F, Nicolini G, Amato R, et al. Local modulation of thyroid hormone signaling in the retina affects the development of diabetic retinopathy. Biochim Biophys Acta Mol Basis Dis. 2024;1870(1):166892. doi:10.1016/j.bbadis.2023.166892
   PubMed Web of Science ®Google Scholar
• Gao X, Wang X, Zhong Y, et al. Serum antithyroglobulin antibody levels are associated with diabetic retinopathy among euthyroid type 2 diabetes patients: a hospital-based, retrospective study. J Diabetes Res. 2022;2022:2552186. doi:10.1155/2022/2552186
   PubMed Web of Science ®Google Scholar
• Liu Y, Yang J, Tao L, et al. Risk factors of diabetic retinopathy and sight-threatening diabetic retinopathy: a cross-sectional study of 13 473 patients with type 2 diabetes mellitus in mainland China. BMJ Open. 2017;7(9):e016280. doi:10.1136/bmjopen-2017-016280
   PubMed Web of Science ®Google Scholar
• Busik JV. Lipid metabolism dysregulation in diabetic retinopathy. J Lipid Res. 2021;62:100017. doi:10.1194/jlr.TR120000981
   PubMed Web of Science ®Google Scholar
• Kowluru RA. Diabetic retinopathy and NADPH oxidase-2: a sweet slippery road. Antioxidants. 2021;10(5):783. doi:10.3390/antiox10050783
   Web of Science ®Google Scholar
• Xuan Q, Zheng F, Yu D, et al. Rapid lipidomic profiling based on ultra-high performance liquid chromatography-mass spectrometry and its application in diabetic retinopathy. Anal Bioanal Chem. 2020;412(15):3585–3594. doi:10.1007/s00216-020-02632-6
   PubMed Web of Science ®Google Scholar
• Ezhilvendhan K, Sathiyamoorthy A, Prakash BJ, et al. Association of dyslipidemia with diabetic retinopathy in type 2 diabetes mellitus patients: a hospital-based study. J Pharm Bioallied Sci. 2021;13(Suppl 2):S1062–S1067. doi:10.4103/jpbs.jpbs_164_21
   PubMedGoogle Scholar
• Tung TH, Chen SJ, Liu JH, et al. A community-based follow-up study on diabetic retinopathy among type 2 diabetics in Kinmen. EUR J EPIDEMIOL. 2005;20(4):317–323. doi:10.1007/s10654-004-6651-z
   PubMed Web of Science ®Google Scholar
• Zhang HY, Wang JY, Ying GS, et al. Serum lipids and other risk factors for diabetic retinopathy in Chinese type 2 diabetic patients. J Zhejiang Univ Sci B. 2013;14(5):392–399. doi:10.1631/jzus.B1200237
   PubMed Web of Science ®Google Scholar
• DeFronzo RA, Ferrannini E, Groop L, et al. Type 2 diabetes mellitus. NAT REV DIS PRIMERS. 2015;1:15019. doi:10.1038/nrdp.2015.19
   PubMed Web of Science ®Google Scholar
• Menon PS, Vaidyanathan B, Kaur M. Autoimmune thyroid disease in Indian children with type 1 diabetes mellitus. J Pediatr Endocrinol Metab. 2001;14(3):279–286. doi:10.1515/JPEM.2001.14.3.279
   PubMed Web of Science ®Google Scholar
• Zhang YJ, Zhao W, Zhu MY, et al. Thyroid-stimulating hormone induces the secretion of tumor necrosis factor-alpha from 3T3-L1 adipocytes via a protein kinase A-dependent pathway. Exp Clin Endocrinol Diabetes. 2013;121(8):488–493. doi:10.1055/s-0033-1347266
   PubMed Web of Science ®Google Scholar
• van de Woestijne AP, Monajemi H, Kalkhoven E, et al. Adipose tissue dysfunction and hypertriglyceridemia: mechanisms and management. Obes Rev. 2011;12(10):829–840. doi:10.1111/j.1467-789X.2011.00900.x
   PubMed Web of Science ®Google Scholar
• Pazos F, Alvarez JJ, Rubies-Prat J, et al. Long-term thyroid replacement therapy and levels of lipoprotein(a) and other lipoproteins. J Clin Endocrinol Metab. 1995;80(2):562–566. doi:10.1210/jcem.80.2.7852521
   PubMed Web of Science ®Google Scholar
• Gu L, Yang J, Gong Y, et al. Lower free thyroid hormone levels are associated with high blood glucose and insulin resistance; these normalize with metabolic improvement of type 2 diabetes. J Diabetes. 2021;13(4):318–329. doi:10.1111/1753-0407.13118
   PubMed Web of Science ®Google Scholar
• Lin Y, Sun Z. Thyroid hormone potentiates insulin signaling and attenuates hyperglycemia and insulin resistance in a mouse model of type 2 diabetes. Br J Pharmacol. 2011;162(3):597–610. doi:10.1111/j.1476-5381.2010.01056.x
   PubMed Web of Science ®Google Scholar
• Condorelli RA, Cannarella R, Aversa A, et al. Effects of slow-acting metformin treatment on the hormonal and morphological thyroid profile in patients with insulin resistance. Pharmaceutics. 2022;14(10):1987. doi:10.3390/pharmaceutics14101987
   PubMed Web of Science ®Google Scholar
• Pappa T, Alevizaki M. Metformin and thyroid: an update. Eur Thyroid J. 2013;2(1):22–28. doi:10.1159/000346248
   PubMedGoogle Scholar